EX-99.4 4 ea028544601ex99-4.htm UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF HEALTHCARE TRIANGLE, INC., TEYAME 360 S.L. AND DATONO MEDIACION S.L

Exhibit 99.4

 

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

 

The unaudited pro forma condensed combined financial data should be read in conjunction with the historical financial statements and the accompanying notes of Healthcare Triangle, Inc., and the standalone financial statements of Teyame 360 SL and Datono Mediacion SL respectively, filed herewith.

 

The unaudited pro forma information is not necessarily indicative of the combined company’s actual financial position or actual results of operations had the transaction occurred as of the dates indicated. In addition, the unaudited pro forma condensed combined financial information is not intended to project the future financial position or operating results of the combined company. There were no material transactions between Healthcare Triangle, Inc, Teyame 360 SL and Datono Mediacion SL, during the periods presented in the unaudited pro forma condensed combined financial information that would need to be eliminated.

 

The unaudited pro forma condensed combined financial information does not reflect any cost savings, operating synergies, fair value impacts upon acquisition, or revenue enhancements that the combined company may achieve and realize as a result of the acquisition; nor does it reflect costs to integrate the operations of Healthcare Triangle, Inc Teyame 360 SL and Datono Mediacion SL, or the costs necessary to achieve cost savings, operating synergies and revenue enhancements.

 

 

 

Healthcare Triangle, Inc and Subsidiaries

 

UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEETS

 

As At December 31, 2025

 

(in thousands, except per share data)

 

   HCTI   Teyame   Datono  

HCTI

Pro Forma Combined

 
   (Unaudited)   (Audited)   (Audited)   (Unaudited) 
Assets                
Current assets                
Cash and cash equivalents  $7,625   $2   $0   $7,627 
Accounts receivable   2,070    4,740    773    7,583 
Other current assets   3,456    694    27    4,177 
Total current assets   13,151    5,436    800    19,387 
Furniture and equipment, net   5    1,494    -    1,499 
Goodwill, net   2,946    -    -    2,946 
Intangible assets, net   2,808    2,222    750    5,780 
Other non-current assets   -    207         207 
Due from affiliates   3,826    -    -    3,826 
Total assets  $22,736   $9,359   $1,550   $33,645 
Liabilities and stockholders’ equity (deficit)                    
Current liabilities                    
Accounts payable  $744   $2,939   $741   $4,424 
Short term borrowing   10,737    3,444    2,201    16,382 
Other current liabilities   1,311    798    409    2,518 
Total current liabilities   12,792    7,181    3,351    23,324 
Long-term liabilities                    
Long-term liabilities   -    559    -    559 
Contingent consideration   -    -    -    - 
Total current and long-term liabilities   12,792    7,740    3,351    23,883 
Stockholders’ equity                    
Series B Preferred Stock, par value $0.00001; 10,000,000 authorized issued convertible preferred stock 1,600,000 as of December 31, 2025   7,435    -    -    7,435 
Common stock, par value $0.00001; 100,000,000 authorized 142,426 shares issued and outstanding as of December 31, 2025   11    -    -    11 
Non-controlling interest   (37)   -    -    (37)
Additional paid-in capital   45,534    2,839    (2,834)   45,539 
Retained earnings   (42,999)   (1,220)   1,033    (43,186)
Total stockholders’ equity (deficit)   9,944    1,619    (1,801)   9,762 
Total liabilities and stockholders’ equity  $22,736   $9,359   $1,550   $33,645 

 

 

 

Healthcare Triangle, Inc and Subsidiaries

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

 

Year Ended December 31, 2025

 

(in thousands, except per share data)

 

  

HCTI 

   Teyame   Datono  

HCTI

Pro Forma Combined

 
   (Unaudited)   (Audited)   (Audited)   (Unaudited) 
Net revenue  $13,891   $17,161   $13,763   $44,815 
Cost of revenue (exclusive of depreciation and amortization shown separately below)   12,001    9,263    11,647    32,911 
Bad debt expense   17    -    -    17 
Research and development   536    -    -    536 
Sales and marketing   3,084    2,556    1,176    6,816 
General and administrative   7,337    2,794    71    10,202 
Depreciation and amortization   705    882    170    1,757 
Total operating expenses   11,679    6,232    1,417    19,328 
Gain/(loss) from operations   (9,789)   1,666    699    (7,424)
Other income   857    13    28    898 
Changes in fair value   41    -    -    41 
Forex gain/(loss)   (18)   -    -    (18)
Interest expense   (567)   (214)   (114)   (895)
Income/(Loss) before income taxes   (9,476)   1,465    613    (7,398)
                     
Income tax expense   -    (362)   (147)   (509)
                     
Net income / (loss)   (9,476)   1,103    466    (7,907)
Other comprehensive income/(loss)                    
Foreign currency translation gain   11    -    -    11 
Comprehensive loss  $(9,465)  $1,103   $466   $(7,896)
Comprehensive loss attributable to:                    
Stockholders   (9,428)   1,103    466    (7,859)
Non-controlling interest   (37)   -    -    (37)
Net loss per common share—basic and diluted                    
Stockholders   (152.3)   -    -    (127)
Non-controlling interest   (0.6)   -    -    (0.6)
Weighted average shares outstanding used in per common share computations:                    
Basic and diluted   61,873    -    -    61,873